MedPath

Kunwha Pharmaceutical Co., Ltd.

🇰🇷South Korea
Ownership
Private
Employees
-
Market Cap
-
Website

Efficacy and Safety of KW21052 Compared to Lyrica in the Diabetic Patients With Neuropathic Pain

Phase 3
Conditions
Diabetic Neuropathy
Interventions
First Posted Date
2013-05-29
Last Posted Date
2013-05-29
Lead Sponsor
KunWha Pharmaceutical Co., Ltd.
Target Recruit Count
394
Registration Number
NCT01863810
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath